Publication | Closed Access

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

VaccinationVaccine SafetyVaccine DevelopmentMrna RabiesImmunologyVaccine TestingMedicineVaccine ResearchHealthy Adults